A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis. uri icon

authors

  • Tavazzi, Eleonora
  • Leppert, David
  • Dwyer, Michael G
  • Weinstock-Guttman, Bianca
  • Benedict, Ralph H B
  • Zivadinov, Robert
  • Bergsland, Niels
  • Kuhle, Jens
  • Dejan Jakimovski MD, PhD
  • Ramanathan, Murali
  • Maceski, Aleksandra M
  • Tomic, Davorka
  • Hagemeier, Jesper
  • Kropshofer, Harald

publication date

  • January 1, 2019